Sonomind announced that it raised $23.5 million (€20 million) in its Series A funding round led by Critical Path Ventures and Bpifrance.
The French startup specializes in non-invasive, painless therapy for mental illnesses using focused...
Sonomind announced that it raised $23.5 million (€20 million) in its Series A funding round led by Critical Path Ventures and Bpifrance.
The French startup...
Aurie announced that it received FDA de novo clearance for its Aurie Reusable No-Touch Intermittent Catheter System.
The Syracuse, New York-based company says the milestone...
Bright Uro’s Glean abdominal sensor has obtained US Food and Drug Administration (FDA) clearance, expanding the company’s broader Glean urodynamics system to include multi-channel...
Reprieve Cardiovascular announced the publication of results from a pilot study of its heart failure therapy.
Milford, Massachusetts-based Reprieve Cardiovascular develops the Reprieve Therapy. It...
Reprieve Cardiovascular announced the publication of results from a pilot study of its heart failure therapy.
Milford, Massachusetts-based Reprieve Cardiovascular develops the Reprieve Therapy. It...
Medical Microinstruments (MMI) announced the completion of the first robotic-assisted procedure in its REMIND U.S. IDE study.
REMIND evaluates microsurgical intervention for neurodegenerative disease. MMI...
CVRx announced that it enrolled the first patient in its landmark BENEFIT-HF study of its Barostim therapy.
Barostim delivers electrical pulses to baroreceptors in the...
Sensome announced the publication of first-in-human results from the CLOT OUT study evaluating its Clotild smart guidewire system.
Findings published in the Journal of Neurointerventional...
Sonomind announced that it raised $23.5 million (€20 million) in its Series A funding round led by Critical Path Ventures and Bpifrance.
The French startup...
Aurie announced that it received FDA de novo clearance for its Aurie Reusable No-Touch Intermittent Catheter System.
The Syracuse, New York-based company says the milestone...
Bright Uro’s Glean abdominal sensor has obtained US Food and Drug Administration (FDA) clearance, expanding the company’s broader Glean urodynamics system to include multi-channel...
Reprieve Cardiovascular announced the publication of results from a pilot study of its heart failure therapy.
Milford, Massachusetts-based Reprieve Cardiovascular develops the Reprieve Therapy. It...